Androgen Blockade and Progesterone Augmentation of Gonadotropin Secretion

Recruiting

Early Phase 1

Androgen Blockade & ProgesteroneAndrogen Blockade and Progesterone Augmentation of Gonadotropin Secretion

Sponsor:

University of Virginia

Code:

NCT04597099

Conditions

PCOS

Polycystic Ovary Syndrome

Eligibility Criteria

Sex: Female

Age: 18 - 30

Healthy Volunteers: Accepted

Interventions

Micronized progesterone

Placebo

Flutamide

Estradiol patch

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-16. This information was provided to ClinicalTrials.gov by University of Virginia on 2023-11-02.